The Cochrane Infectious Diseases Group (CIDG) editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK.

Tuberculosis kills 5,000 people every day and over 1,000 people fall sick with TB each day. The great majority of these are the poorest members of our society, with limited access to healthcare and no resources to cope with illness. We know that for any infectious disease the best way to control epidemics is either through vaccines or finding and treating every case to prevent transmission. The only TB vaccine, BCG, is not very effective and this has allowed TB to continue to kill millions of people every year.

_{Members of the IMPPACT Consortium}

_{Back Left: Tracy Seddon, Patrick Walker, Mwayi Madanitsa, Feiko Ter Kuile, Simon Kariuki, Cheryl Giddings | Front Left: Meghna Desai, Annemieke van Eijk, Jayne Webster, Jenny Hill}

The Malaria Genomic Epidemiology Network (MalariaGEN) is an international community of researchers working to understand how genetic variation in humans,Plasmodium parasites, and Anopheles mosquitoes affects the biology and epidemiology of malaria, and using this knowledge to develop more effective ways to control the disease.

MalariaGEN is a scientific network that connects researchers and clinicians in malaria-endemic countries with cutting-edge DNA sequencing technologies and genomic research.

Through a number of multi-centre projects, we provide a framework for generating, integrating and sharing genetic and genomic data, and for investigating key questions about malaria biology and epidemiology. Learn more about how genomics can help to defeat malaria.

The network is coordinated by the MalariaGEN Resource Centre whose members are based primarily at the Wellcome Trust Centre for Human Genetics at the University of Oxford and at the Wellcome Trust Sanger Institute on the Wellcome Genome Campus.

With funding from a Wellcome Trust Collaborative Award, LSTM with partners CNRFP in Burkina Faso, University of Glasgow, University of Durham, Warwick University, Univesity of Oxford and Imperial College have initiated a new three year study on Malaria in Insecticide Resistant Africa (MIRA). This project will quantify the public health impact of insecticide resistance and estimate the finances required to meet malaria control targets in high burden countries where malaria is stubbornly persistent.

RECAP-SL is a €250,000 funded project under the 2nd European & Developing Countries Clinical Trials Partnership (EDCTP2) programme. 

Read-It is a UKAID funded research and development grant that has a single key performance indicator:

Increased number of evidence-informed decisions by global, regional and national decision-makers that benefit the poor, including women 

Key institutions partner in the analysis of a range of environmental, social and economic indicators to answer the question whether life in the Tropics is getting better. The resulting 2014 report provides the first in-depth, objective assessment of the Tropics as an environmental and geopolitical entity in its own right. Drawing on the knowledge, experience and diverse backgrounds of leading institutions the report assesses the state of the region and provide a foundation for policy makers, geopolitical analysts and other stakeholders to examine in greater detail the tropics and the major issues affecting it.

The Centre for Research in Infectious Diseases (CRID)is a research Centre located in Yaoundé, Cameroon, and is hosting a research unit from LSTM under the leadership of Wellcome Trust Senior Fellow, Professor Charles Wondji.